Teva to demonstrate how they have adapted Bridging ELISA to achieve required Drug Tolerance for ADA Detection of Therapeutic Antibodies
SMi's 2nd annual Immunogenicity conference, taking place on the 29th & 30th June 2015 in London, will feature an array of case studies from big pharma and biotech companies pioneering the way in cutting-edge Immunogenicity developments.
- (1888PressRelease) June 23, 2015 - SMi's 2nd annual Immunogenicity conference, taking place on 29-30 June 2015 in London, will provide the ideal platform for the pharmaceutical industry, clinicians and academic scientists to align concepts and practices related to immunogenicity. The two-day conference programme will feature an array of case study driven presentations delivered by leading drug development teams, bioanalytical experts, and academics from organisations including Apitope International NV, EpiVax, Inc, Roche Innovation Center Penzberg, UCB, Swedish Orphan Biovitrum and more.
Unique perspectives will be shared on:
• Immunogenicity challenges in biologics development
• Tolerance induction techniques
• The latest in pre-clinical models
• Neutralising antibody assay best practice
• Updates on the ABIRISK project
Furthermore, we are delighted to announce that Teva's Director of Experimental Immunology, Linglong Zou, will be leading a presentation titled 'Mission Impossible? Tweaking Bridging ELISA to Achieve Required Drug Tolerance for ADA Detection of Therapeutic Antibodies' at SMi's Immunogenicity conference on Day 1.
He will be sharing his unique insight on the following topic areas:
• An updated view of drug tolerance requirement for an ADA assay
• Benefit of achieving adequate drug tolerance for immunogenicity testing and data reporting
• Advantage of non-acid dissociation method for drug tolerance improvement
• Case study illustrating how to tweak Bridging ELISA to enhance drug tolerance
To view the full speaker line-up and conference programme, visit http://www.immuno.co.uk/1888pressrelease
###
space
space
Contact Information
- Vinh Trinh
- Smi Group
- Unit 122/124 Great Guildford Business Square, 30 Great Guildford Street, London
- SE1 0BS
- Voice: 44 (0) 20 7827 6140
- Visit our Site
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam